Connect
MJA
MJA

Direct-to-consumer genetic testing — where should we focus the policy debate?

Timothy Caulfield and Pascal Borry
Med J Aust 2013; 198 (9): . || doi: 10.5694/mja12.11024
Published online: 20 May 2013

What are the implications for health systems, children and informed public debate?

Until recently, human genetic tests were usually performed in clinical genetics centres. In this context, tests are provided under specific protocols that often include medical supervision, counselling and quality assurance schemes that assess the value of the genetic testing services. Direct-to-consumer (DTC) genetic testing companies operate outside such schemes, as noted by Trent in this issue of the Journal.1 While the uptake of DTC genetic testing has been relatively modest, the number of DTC genetic testing services continues to grow.2 Although the market continues to evolve,3 it seems likely that the DTC genetic testing industry is here to stay.


  • 1 Faculty of Law and School of Public Health, University of Alberta, Edmonton, Canada.
  • 2 Department of Public Health and Primary Care, Katholieke Universiteit Leuven, Leuven, Belgium.


Correspondence: tcaulfld@law.ualberta.ca

Acknowledgements: 

We thank Robyn Hyde-Lay and Zubin Master for research support and AllerGen (Networks of Centres of Excellence of Canada) and the Interdisciplinary Chronic Disease Collaboration for funding support.

Competing interests:

No relevant disclosures.

  • 1. Trent RJ. Direct-to-consumer genetic testing — clinical considerations. Med J Aust 2013; 198: 1-3.
  • 2. Hock KT, Christensen KD, Yashar BM, et al. Direct-to-consumer genetic testing: an assessment of genetic counselors’ knowledge and beliefs. Genet Med 2011; 13: 325-332.
  • 3. Borry P, Cornel MC, Howard HC. Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market. J Community Genet 2010; 1: 101-106.
  • 4. Borry P, van Hellemondt RE, Sprumont D, et al. Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet 2012; 20: 715-721.
  • 5. Caulfield T, McGuire AL. Direct-to-consumer genetic testing: perceptions, problems, and policy responses. Annu Rev Med 2012; 63: 23-33.
  • 6. Nicol D, Hagger M. Direct-to-consumer genetic testing — a regulatory nightmare? Med J Aust 2013; 198: 501-502.
  • 7. Australian Law Reform Commission. Essentially yours: the protection of human genetic information in Australia. ALRC Report 96. 2003. http://www.alrc.gov.au/publications/report-96 (accessed Mar 2013).
  • 8. Skirton H, Goldsmith L, Jackson L, O’Connor A. Direct to consumer genetic testing: a systematic review of position statements, policies and recommendations. Clin Genet 2012; 82: 210-218.
  • 9. Caulfield T, Condit C. Science and the sources of hype. Public Health Genomics 2012; 15: 209-217.
  • 10. James KM, Cowl CT, Tilburt JC, et al. Impact of direct-to-consumer predictive genomic testing on risk perception and worry among patients receiving routine care in a preventive health clinic. Mayo Clin Proc 2011; 86: 933-940.
  • 11. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 2011; 364: 524-534.
  • 12. Terhune C. Spending on genetic tests is forecast to rise sharply by 2021. Los Angeles Times 2012; 12 Mar. http://articles.latimes.com/2012/mar/12/business/la-fi-genetic-test-20120312 (accessed Mar 2013).
  • 13. Leighton JW, Valverde K, Bernhardt BA. The general public’s understanding and perception of direct-to-consumer genetic test results. Public Health Genomics 2012; 15: 11-21.
  • 14. Powell KP, Cogswell WA, Christianson CA, et al. Primary care physicians’ awareness, experience and opinions of direct-to-consumer genetic testing. J Genet Couns 2011; 21: 113-126.
  • 15. Borry P, Howard HC, Sénécal K, Avard D. Health-related direct-to-consumer genetic testing: a review of companies’ policies with regard to genetic testing in minors. Fam Cancer 2010; 9: 51-59.
  • 16. Human Genetics Society of Australasia. Pre symptomatic testing in children and young adults. Position statement. 2008. https://www.hgsa.org.au/website/wp-content/uploads/2009/12/2008PS02-Pre-symptomatic-predictive-testing-in-children-young-people.pdf (accessed Mar 2013).
  • 17. Geransar R, Einsiedel E. Evaluating online direct-to-consumer marketing of genetic tests: informed choices or buyers beware? Genet Test 2008; 12: 13-23.
  • 18. US Government Federal Trade Commission. At-home genetic tests. Consumer information. 2013. http://www.consumer.ftc.gov/articles/0166-home-genetic-tests (accessed Mar 2013).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.